EL
30
-3
TAP
45
-6
ESS
60
-8
DHR
56
-4
CHK
48
15
HP
41
-4
MMC
58
-2
QCOM
55
-4
VLO
40
-5
AMG
41
-3
DIS
60
2
PEG
76
5
UPS
55
-6
MNST
49
-3
TGNA
48
-2
ETR
68
2
NRG
69
12
EXC
53
6
VRSN
53
-2
WBA
24
-3
EL
30
-3
TAP
45
-6
ESS
60
-8
DHR
56
-4
CHK
48
15
HP
41
-4
MMC
58
-2
QCOM
55
-4
VLO
40
-5
AMG
41
-3
DIS
60
2
PEG
76
5
UPS
55
-6
MNST
49
-3
TGNA
48
-2
ETR
68
2
NRG
69
12
EXC
53
6
VRSN
53
-2
WBA
24
-3
Financhill
Back

NexGen Energy Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
35

NXE.TO
NexGen Energy

Last Price:
8.48
Seasonality Move:
0.51%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
35
NexGen Energy (NXE.TO) is a Sell

Is NexGen Energy a Buy, Sell or Hold?

  • The current NexGen Energy [NXE.TO] share price is $8.48. The Score for NXE.TO is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • NXE.TO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

NXE.TO Stock Price Chart

What is NexGen Energy's stock price today?

  • The NexGen Energy share price today is $8.48
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NXE.TO is experiencing slight selling pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

NXE.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 60 Buy
Chaikin Money Flow: -3229314 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.51 - 8.33) Buy
Bollinger Bands (100): (8.04 - 10.36) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

NXE.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.91 Buy
20-day SMA: 7.87 Buy
50-day SMA: 8.29 Buy
200-day SMA: 9.64 Sell
8-day EMA: 7.96 Buy
20-day EMA: 7.91 Buy
50-day EMA: 8.3 Buy
200-day EMA: 8.96 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

NexGen Energy Earnings Growth & NXE.TO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.01 per share, an increase this year of $0.08 per share, and a decrease next year of $0.04 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

NexGen Energy Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):